Generic Drug Approvals Still Winning The Pandemic At US FDA

Approvals Peak In June As Complete Responses Fall To A Low

 
• By Derrick Gingery

Productivity remains high as full ANDA approvals reached a FY 2020 peak and complete responses dropped to another low in June.

Building icon with inscription FDA and flag of The United States over abstract background. - Illustration
The FDA said several recent ANDA approvals came through its commitment to work past a goal date if approval was imminent • Source: Shutterstock

More from Generics

More from Products